Pharmaceutical - Financial

Filter

Current filters:

Financial

Popular Filters

1 to 25 of 1090 results

Eli Lilly's fourth quarter financials hit by patent expiries and currency issues

Eli Lilly's fourth quarter financials hit by patent expiries and currency issues

30-01-2015

US drugmaker Eli Lilly’s fourth quarter financials were hit by genericization and currency fluctuations,…

CymbaltaEli LillyEvistaFinancialPharmaceutical

Strong sales and earnings growth for Novo Nordisk in 2014

30-01-2015

Danish diabetes care giant Novo Nordisk posted financials this morning, showing that sales for full-year…

DiabetesFinancialNovo NordiskPharmaceutical

Abbott's last quarter 2014 results come in below estimates

Abbott's last quarter 2014 results come in below estimates

29-01-2015

Currency fluctuations are a cause for concern for US health care company Abbott Laboratories, as it reports…

AbbottAbbott LaboratoriesFinancialPharmaceuticalUSA

Baxter says record 2014 results set solid foundation for planned separation

29-01-2015

US drugmaker Baxter International today announced fourth quarter 2014 financial results that exceeded…

Baxter InternationalFinancialPharmaceutical

GSK and Novartis get European clearance for asset swap

GSK and Novartis get European clearance for asset swap

29-01-2015

UK pharma major GlaxoSmithKline has received clearance from the European Commission for its proposed…

EuropeFinancialGlaxoSmithKlineNovartisOncologyPharmaceuticalUK

Roche’s 2014 profits miss forecasts, impacted by costs

Roche’s 2014 profits miss forecasts, impacted by costs

28-01-2015

Despite posting higher sales for full-year 2014, Swiss pharma major Roche missed analysts’ forecasts,…

FinancialPharmaceuticalReutersRocheUnited States

Beximco Pharma borrows $51.5 million to fund expansion

28-01-2015

Bangladesh-based Beximco Pharmaceuticals has entered into a new loan agreement to borrow up to $51.559…

BangladeshBeximco PharmaBeximco PharmaceuticalsFinancialPharmaceutical

Fourth quarter Bristol-Myers Squibb results disappoint

Fourth quarter Bristol-Myers Squibb results disappoint

27-01-2015

Although the fourth quarter financial results from US drug major Bristol-Myers Squibb beat analyst estimates,…

Bristol-Myers SquibbFinancialPharmaceuticalUnited StatesUSA

Pfizer’s 4th-qtr 2014 beats forecasts, but guidance disappoints

Pfizer’s 4th-qtr 2014 beats forecasts, but guidance disappoints

27-01-2015

US pharma giant Pfizer today reported fourth-quarter 2014 earnings of $1.23 billion, and net earnings…

Corporate crimeDow Jones Industrial AverageFinancialPfizerPharmaceutical

Novartis sees negative currency impact in 4th-qtr 2014; gives positive 2015 guidance

Novartis sees negative currency impact in 4th-qtr 2014; gives positive 2015 guidance

27-01-2015

Swiss pharma major Novartis, now the world’s largest drugmaker by sales, this morning posted financial…

FinancialNovartisPharmaceutical

CIPA and KEFEA discuss initiatives to improve Cyprus’ pharma investment climate

26-01-2015

The potential to attract investments in the pharmaceutical industry and develop joint initiatives to…

FinancialHealthcarePharmaceuticalRest of the World

US Senator plans legislation to advance medical research

23-01-2015

In remarks at the Families USA Health Action Conference in Washington DC on January 22, US Senator Elizabeth…

FinancialLegalPharmaceuticalResearchUSA

Leading Russian drug producers call for state support measures

Leading Russian drug producers call for state support measures

23-01-2015

Leading Russian drug producers have called on the national parliament (State Duma) for a complex of measures…

BiotecFinancialPharmaceuticalPolisanPricingProductionRussia

Ukraine drug imports declined by almost 30% in 2014

Ukraine drug imports declined by almost 30% in 2014

23-01-2015

Drug imports to Ukraine in 2014 decreased by almost 30%, compared to 2013, according to the Ukrainian…

FinancialKievan Rus'Markets & MarketingPharmaceuticalUkraine

Johnson & Johnson beats profit forecasts, but group sales shy

Johnson & Johnson beats profit forecasts, but group sales shy

20-01-2015

US health care giant Johnson & Johnson has reported financial results for the fourth-quarter and full-year…

FinancialJohnson and JohnsonPharmaceutical

ACOSS proposes alternative evidence-based and equitable savings to Australian health services

19-01-2015

The Australian Council of Social Service (ACOSS) has called on the federal government to heed the growing…

AustraliaFinancialHealthcarePharmaceutical

Report: Denmark’s pharma market expected to drop to $3 billion by 2020

Report: Denmark’s pharma market expected to drop to $3 billion by 2020

14-01-2015

Denmark’s pharmaceutical market will decline in value from $3.5 billion in 2013 to $3 billion by 2020,…

DenmarkFinancialMarkets & MarketingPharmaceuticalPricing

NHS England raises budget for Cancer Drugs Fund but axes some products

NHS England raises budget for Cancer Drugs Fund but axes some products

13-01-2015

As has been widely expected and already much criticized, England’s over-stretched Cancer Drugs Fund…

FinancialHealthcareOncologyPharmaceuticalUK

AbbVie issues earnings-per-share guidance up 30% for 2015

AbbVie issues earnings-per-share guidance up 30% for 2015

12-01-2015

US drugmaker AbbVie has issued updated guidance about its expected earnings in 2015.

AbbVieAnti-viralsFinancialHumiraPharmaceuticalUSAViekira Pak

Daiichi Sankyo agees to pay $39 million to settle US kickback allegations

Daiichi Sankyo agees to pay $39 million to settle US kickback allegations

11-01-2015

The US subsidiary of Japanese drug major Daiichi Sankyo has agreed to pay the United States and state…

Daiichi SankyoFinancialMarkets & MarketingPharmaceuticalUSA

Reckitt Benckiser demerger goes through, creating Indivior as pharma arm

Reckitt Benckiser demerger goes through, creating Indivior as pharma arm

23-12-2014

The UK-based consumer goods giant Reckitt Benckiser Group has demerged what was once its USA-based pharma…

FinancialIndivior PLCMergers & AcquisitionsNeurologicalPharmaceuticalReckitt BenckiserUSA

Orexo gets £5 million milestone for Abstral in Europe; Zubsolv continues strong growth in the USA

Orexo gets £5 million milestone for Abstral in Europe; Zubsolv continues strong growth in the USA

18-12-2014

The annual sales in Europe of Abstral, a rapidly-disintegrating, sublingual formulation of fentanyl,…

AbstralFinancialKyowa Hakko KirinLicensingNeurologicalOrexoPharmaceuticalProStrakanZubsolv

Lundbeck to stop further development of desmoteplase

Lundbeck to stop further development of desmoteplase

18-12-2014

Following evaluation of disappointing clinical results, Danish CNS specialists Lundbeck said late yesterday…

Cardio-vasculardesmoteplaseFinancialLundbeckNeurologicalPharmaceuticalResearch

Top 30 Pharmas spent $112 billion on R&D in 2013; report

Top 30 Pharmas spent $112 billion on R&D in 2013; report

17-12-2014

The world’s leading 30 pharmaceutical companies spent a combined $112 billion on research and development…

FinancialGlobalGlobalDataJohnson & JohnsonNovartisPfizerPharmaceuticalPharmaceutical sciencesResearch

1 to 25 of 1090 results

Back to top